Results 281 to 290 of about 223,598 (343)

A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT This UK national audit aimed to assess adherence to evidence‐based chemotherapy‐induced nausea and vomiting (CINV) guidelines for children with cancer, which emphasise treatment emetogenicity assessment, symptom monitoring and appropriate antiemetic use.
Eloise Neumann, Thomas J. Jackson, Jessica E. Morgan, Robert Phillips, Jessica Bate, the CCLG Supportive Care Group   +5 more
wiley   +1 more source

Blinatumomab in pediatric B-acute lymphoblastic leukemia. [PDF]

Front Immunol
Cheng Y, Liu A.
europepmc   +1 more source

Central Adiposity and Visceral Fat in Long‐Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Exploration of an Underappreciated Risk

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Introduction Elevated visceral fat is associated with poor cardiovascular health but is not well characterized in survivors of childhood cancer. We examined central adiposity and associated risk factors in a pediatric acute lymphoblastic leukemia (ALL) survivorship cohort.
Louise Guolla, Ashlyn Chou, Troy H. Farncombe, Lehana Thabane, Katherine Morrison, Ronald D. Barr   +5 more
wiley   +1 more source

Adverse reactions of dasatinib in pediatric acute lymphoblastic leukemia: a retrospective comparative cohort study. [PDF]

Transl Pediatr
Yu LT, Xue Q, Feng Q, Wang Z, Zhang SG, Gu JP.   +5 more
europepmc   +1 more source

Early Toxicity in Childhood Acute Lymphoblastic Leukemia: A Comparison of NOPHO ALL2008 and ALLTogether Protocols in Sweden

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Background The European ALLTogether protocol for childhood acute lymphoblastic leukemia, initiated in Sweden 2019, introduced earlier asparaginase during induction, dexamethasone instead of prednisone for all patients, and omitted anthracyclines from low‐risk induction to reduce treatment‐related toxicity.
Johannes Fermér, Hannah van Bunningen, Otto Zhou, Jonas Abrahamsson, Magnus Borssen, Isabella Donnér, Mats Heyman, Anna Sällfors Holmqvist, Anders Valind, Hartmut Vogt, Susanna Ranta, Arja Harila   +11 more
wiley   +1 more source

An explainable deep learning-based feature fusion model for acute lymphoblastic leukemia diagnosis and severity assessment. [PDF]

Front Med (Lausanne)
Khan H, Sajid MZ, Khan NA, Hamid MF, Youssef A, Rehman A, Aburaed N.   +6 more
europepmc   +1 more source

The role of pharmacogenetics in the therapy regimen of acute lymphoblastic leukemia in children: recent discoveries and future perspectives. [PDF]

Pharmacol Rep
Szoszkiewicz A, Światłowska A, Derwich K, Jamsheer A, Rubiś B, Bienert A.   +5 more
europepmc   +1 more source

Peripheral Blood as a Diagnostic Alternative to Bone Marrow in Immunophenotyping Pediatric B-Cell Acute Lymphoblastic Leukemia. [PDF]

Int J Mol Sci
Saucedo-Campos AD, Lopez Chee MJ, Campos-Aguilar M, Tapia-Sánchez WD, Olivas-Quintero S, Méndez-Cruz AR, Reyes-Reali J, Medoza-Ramos MI, Jiménez-Flores R, Pozo-Molina G, Rosales-García VH, Ponciano-Gómez A.   +11 more
europepmc   +1 more source

Charting the landscape and evolution of research on cell death in acute lymphoblastic leukemia: a comprehensive bibliometric analysis (1990-2024). [PDF]

Discov Oncol
Wang S, Zhang X, Zhang.
europepmc   +1 more source